NextCure, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:NXTC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -12.99 M-22.71 M-6.27 M-7.64 M-13.36 M -49.98 M Cash from investing activities 7.09 M3.76 M8.7 M6 M1.3 M 19.76 M Cash from financing activities 1 000106 K020.29 M1.25 M — Free cash flow -12.99 M-22.71 M-6.27 M-7.64 M-13.36 M -49.98 M

News

3 Cancer Stocks to Watch as Oncology Innovation Accelerates

NextCure, Inc. (NXTC) Discusses Preliminary Phase I Data for SIM0505 in Platinum-Resistant Ovarian Cancer and Uterine Serous Carcinoma - Slideshow (NASDAQ:NXTC) 2026-06-02

NextCure provides updates on ADC programs, reports cash position

NextCure secures $21.5 million in private placement to extend cash runway

NextCure raises $21.5 million in private placement to fund ADC programs

Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect?

Curanex Pharmaceuticals closes $15 million IPO on NASDAQ

NextCure (NXTC) Q2 Loss Widens 71%

NextCure stock soars after positive data for bone disease treatment

Why Deckers Outdoor Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Absci (NASDAQ:ABSI), AST SpaceMobile (NASDAQ:ASTS)

Piper Sandler lowers NextCure stock price target to $15 after reverse split

NextCure initiates one-for-twelve reverse stock split on Nasdaq